Clinical Research Hub
Live Research Database

Eczema
Hub: Tampa, FL

Connecting patients in Tampa with breakthrough clinical trials, specialized care, and study-related compensation.

User
User
User
User
+4k
Join 4,200+ participants tracking trials in Florida

Available Eczema Opportunities

9 Recruiting
NCT06863961(Verify)

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema
NCT05995964(Verify)

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

RECRUITING
Eczema
NCT07037901(Verify)

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

RECRUITING
Eczema
NCT06311682(Verify)

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

RECRUITING
Eczema
NCT07150845(Verify)

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

RECRUITING
Eczema
NCT06241118(Verify)

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

RECRUITING
Eczema
NCT06389136(Verify)

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

RECRUITING
Eczema
NCT06988605(Verify)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

RECRUITING
Eczema
NCT07105488(Verify)

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema

Patient Safeguards

IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks

"Advancing Eczema research in Tampa through safe, transparent, and patient-first clinical trials."

ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT